Skip to content
News Radio KOTA
    • Sample Page
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market

Author: BioMedWire

Posted Date:

June 24, 2026
  • Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market

    BioMedWire
    June 24, 2026
  • The Quest to Repair What Multiple Sclerosis Takes Away

    BioMedWire
    June 24, 2026
  • Next-Generation DNA Repair Therapies Open New Frontiers in Oncology

    BioMedWire
    June 22, 2026
  • Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

    BioMedWire
    June 22, 2026
  • Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion

    BioMedWire
    June 3, 2026
  • How Advanced Drug Delivery Could Improve Existing Cancer Treatments

    BioMedWire
    June 1, 2026
  • Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities

    BioMedWire
    May 13, 2026
  • CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research

    BioMedWire
    May 13, 2026
  • The Future of Intoxication Detection May Be in Your Voice

    BioMedWire
    May 12, 2026
  • CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities

    BioMedWire
    May 11, 2026
1 2
Next